![]() |
Trials |
Open label multicenter Phase I/II study of the safety and efficacy of PDR001 administered to patients with advanced malignanciesCancer type: Thyroid cancer Phase: I/II Principal Investigator: Brunsvig Paal Country: NO Keywords: Norway, Oslo, ATC, PDR001, Novartis Status: Inclusion completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02404441?term=CPDR001X2101&rank=1 |